Global Mesalazine API Market Growth 2025-2031
The global Mesalazine API market size is predicted to grow from US$ 188 million in 2025 to US$ 235 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.
Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.
With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.
Global key players of Mesalazine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalazine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.
LP Information, Inc. (LPI) ' newest research report, the “Mesalazine API Industry Forecast” looks at past sales and reviews total world Mesalazine API sales in 2024, providing a comprehensive analysis by region and market sector of projected Mesalazine API sales for 2025 through 2031. With Mesalazine API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mesalazine API industry.
This Insight Report provides a comprehensive analysis of the global Mesalazine API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mesalazine API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mesalazine API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mesalazine API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mesalazine API.
This report presents a comprehensive overview, market shares, and growth opportunities of Mesalazine API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Mesalazine API market?
What factors are driving Mesalazine API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mesalazine API market opportunities vary by end market size?
How does Mesalazine API break out by Type, by Application?
Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.
With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.
Global key players of Mesalazine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalazine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.
LP Information, Inc. (LPI) ' newest research report, the “Mesalazine API Industry Forecast” looks at past sales and reviews total world Mesalazine API sales in 2024, providing a comprehensive analysis by region and market sector of projected Mesalazine API sales for 2025 through 2031. With Mesalazine API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mesalazine API industry.
This Insight Report provides a comprehensive analysis of the global Mesalazine API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mesalazine API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mesalazine API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mesalazine API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mesalazine API.
This report presents a comprehensive overview, market shares, and growth opportunities of Mesalazine API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Above 97 %
- Above 98 %
- Above 99 %
- Tablets
- Capsules
- Granule
- Suppository
- Enema
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- PharmaZell
- Syntese A/S
- Cambrex Corporation
- Divis Laboratories
- Chemi SpA
- Ipca Laboratories
- Hangzhou Brother
- Lianyungang Fengheng Biopharm
- Lasa Loboratory
- Corden Pharma Bergamo
- Erregierre SpA
- CTX Lifescience
- Ishita Active Pharma Ingredients
- YC Biotech (Jiangsu)
- Xinxiang Tianfeng Fine Chemical
What is the 10-year outlook for the global Mesalazine API market?
What factors are driving Mesalazine API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mesalazine API market opportunities vary by end market size?
How does Mesalazine API break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mesalazine API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Mesalazine API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Mesalazine API by Country/Region, 2020, 2024 & 2031
2.2 Mesalazine API Segment by Type
2.2.1 Above 97 %
2.2.2 Above 98 %
2.2.3 Above 99 %
2.3 Mesalazine API Sales by Type
2.3.1 Global Mesalazine API Sales Market Share by Type (2020-2025)
2.3.2 Global Mesalazine API Revenue and Market Share by Type (2020-2025)
2.3.3 Global Mesalazine API Sale Price by Type (2020-2025)
2.4 Mesalazine API Segment by Application
2.4.1 Tablets
2.4.2 Capsules
2.4.3 Granule
2.4.4 Suppository
2.4.5 Enema
2.4.6 Others
2.5 Mesalazine API Sales by Application
2.5.1 Global Mesalazine API Sale Market Share by Application (2020-2025)
2.5.2 Global Mesalazine API Revenue and Market Share by Application (2020-2025)
2.5.3 Global Mesalazine API Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Mesalazine API Breakdown Data by Company
3.1.1 Global Mesalazine API Annual Sales by Company (2020-2025)
3.1.2 Global Mesalazine API Sales Market Share by Company (2020-2025)
3.2 Global Mesalazine API Annual Revenue by Company (2020-2025)
3.2.1 Global Mesalazine API Revenue by Company (2020-2025)
3.2.2 Global Mesalazine API Revenue Market Share by Company (2020-2025)
3.3 Global Mesalazine API Sale Price by Company
3.4 Key Manufacturers Mesalazine API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mesalazine API Product Location Distribution
3.4.2 Players Mesalazine API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MESALAZINE API BY GEOGRAPHIC REGION
4.1 World Historic Mesalazine API Market Size by Geographic Region (2020-2025)
4.1.1 Global Mesalazine API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Mesalazine API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Mesalazine API Market Size by Country/Region (2020-2025)
4.2.1 Global Mesalazine API Annual Sales by Country/Region (2020-2025)
4.2.2 Global Mesalazine API Annual Revenue by Country/Region (2020-2025)
4.3 Americas Mesalazine API Sales Growth
4.4 APAC Mesalazine API Sales Growth
4.5 Europe Mesalazine API Sales Growth
4.6 Middle East & Africa Mesalazine API Sales Growth
5 AMERICAS
5.1 Americas Mesalazine API Sales by Country
5.1.1 Americas Mesalazine API Sales by Country (2020-2025)
5.1.2 Americas Mesalazine API Revenue by Country (2020-2025)
5.2 Americas Mesalazine API Sales by Type (2020-2025)
5.3 Americas Mesalazine API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mesalazine API Sales by Region
6.1.1 APAC Mesalazine API Sales by Region (2020-2025)
6.1.2 APAC Mesalazine API Revenue by Region (2020-2025)
6.2 APAC Mesalazine API Sales by Type (2020-2025)
6.3 APAC Mesalazine API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mesalazine API by Country
7.1.1 Europe Mesalazine API Sales by Country (2020-2025)
7.1.2 Europe Mesalazine API Revenue by Country (2020-2025)
7.2 Europe Mesalazine API Sales by Type (2020-2025)
7.3 Europe Mesalazine API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mesalazine API by Country
8.1.1 Middle East & Africa Mesalazine API Sales by Country (2020-2025)
8.1.2 Middle East & Africa Mesalazine API Revenue by Country (2020-2025)
8.2 Middle East & Africa Mesalazine API Sales by Type (2020-2025)
8.3 Middle East & Africa Mesalazine API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mesalazine API
10.3 Manufacturing Process Analysis of Mesalazine API
10.4 Industry Chain Structure of Mesalazine API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mesalazine API Distributors
11.3 Mesalazine API Customer
12 WORLD FORECAST REVIEW FOR MESALAZINE API BY GEOGRAPHIC REGION
12.1 Global Mesalazine API Market Size Forecast by Region
12.1.1 Global Mesalazine API Forecast by Region (2026-2031)
12.1.2 Global Mesalazine API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Mesalazine API Forecast by Type (2026-2031)
12.7 Global Mesalazine API Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 PharmaZell
13.1.1 PharmaZell Company Information
13.1.2 PharmaZell Mesalazine API Product Portfolios and Specifications
13.1.3 PharmaZell Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 PharmaZell Main Business Overview
13.1.5 PharmaZell Latest Developments
13.2 Syntese A/S
13.2.1 Syntese A/S Company Information
13.2.2 Syntese A/S Mesalazine API Product Portfolios and Specifications
13.2.3 Syntese A/S Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Syntese A/S Main Business Overview
13.2.5 Syntese A/S Latest Developments
13.3 Cambrex Corporation
13.3.1 Cambrex Corporation Company Information
13.3.2 Cambrex Corporation Mesalazine API Product Portfolios and Specifications
13.3.3 Cambrex Corporation Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Cambrex Corporation Main Business Overview
13.3.5 Cambrex Corporation Latest Developments
13.4 Divis Laboratories
13.4.1 Divis Laboratories Company Information
13.4.2 Divis Laboratories Mesalazine API Product Portfolios and Specifications
13.4.3 Divis Laboratories Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Divis Laboratories Main Business Overview
13.4.5 Divis Laboratories Latest Developments
13.5 Chemi SpA
13.5.1 Chemi SpA Company Information
13.5.2 Chemi SpA Mesalazine API Product Portfolios and Specifications
13.5.3 Chemi SpA Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Chemi SpA Main Business Overview
13.5.5 Chemi SpA Latest Developments
13.6 Ipca Laboratories
13.6.1 Ipca Laboratories Company Information
13.6.2 Ipca Laboratories Mesalazine API Product Portfolios and Specifications
13.6.3 Ipca Laboratories Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ipca Laboratories Main Business Overview
13.6.5 Ipca Laboratories Latest Developments
13.7 Hangzhou Brother
13.7.1 Hangzhou Brother Company Information
13.7.2 Hangzhou Brother Mesalazine API Product Portfolios and Specifications
13.7.3 Hangzhou Brother Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hangzhou Brother Main Business Overview
13.7.5 Hangzhou Brother Latest Developments
13.8 Lianyungang Fengheng Biopharm
13.8.1 Lianyungang Fengheng Biopharm Company Information
13.8.2 Lianyungang Fengheng Biopharm Mesalazine API Product Portfolios and Specifications
13.8.3 Lianyungang Fengheng Biopharm Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Lianyungang Fengheng Biopharm Main Business Overview
13.8.5 Lianyungang Fengheng Biopharm Latest Developments
13.9 Lasa Loboratory
13.9.1 Lasa Loboratory Company Information
13.9.2 Lasa Loboratory Mesalazine API Product Portfolios and Specifications
13.9.3 Lasa Loboratory Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Lasa Loboratory Main Business Overview
13.9.5 Lasa Loboratory Latest Developments
13.10 Corden Pharma Bergamo
13.10.1 Corden Pharma Bergamo Company Information
13.10.2 Corden Pharma Bergamo Mesalazine API Product Portfolios and Specifications
13.10.3 Corden Pharma Bergamo Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Corden Pharma Bergamo Main Business Overview
13.10.5 Corden Pharma Bergamo Latest Developments
13.11 Erregierre SpA
13.11.1 Erregierre SpA Company Information
13.11.2 Erregierre SpA Mesalazine API Product Portfolios and Specifications
13.11.3 Erregierre SpA Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Erregierre SpA Main Business Overview
13.11.5 Erregierre SpA Latest Developments
13.12 CTX Lifescience
13.12.1 CTX Lifescience Company Information
13.12.2 CTX Lifescience Mesalazine API Product Portfolios and Specifications
13.12.3 CTX Lifescience Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 CTX Lifescience Main Business Overview
13.12.5 CTX Lifescience Latest Developments
13.13 Ishita Active Pharma Ingredients
13.13.1 Ishita Active Pharma Ingredients Company Information
13.13.2 Ishita Active Pharma Ingredients Mesalazine API Product Portfolios and Specifications
13.13.3 Ishita Active Pharma Ingredients Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Ishita Active Pharma Ingredients Main Business Overview
13.13.5 Ishita Active Pharma Ingredients Latest Developments
13.14 YC Biotech (Jiangsu)
13.14.1 YC Biotech (Jiangsu) Company Information
13.14.2 YC Biotech (Jiangsu) Mesalazine API Product Portfolios and Specifications
13.14.3 YC Biotech (Jiangsu) Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 YC Biotech (Jiangsu) Main Business Overview
13.14.5 YC Biotech (Jiangsu) Latest Developments
13.15 Xinxiang Tianfeng Fine Chemical
13.15.1 Xinxiang Tianfeng Fine Chemical Company Information
13.15.2 Xinxiang Tianfeng Fine Chemical Mesalazine API Product Portfolios and Specifications
13.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Xinxiang Tianfeng Fine Chemical Main Business Overview
13.15.5 Xinxiang Tianfeng Fine Chemical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mesalazine API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Mesalazine API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Mesalazine API by Country/Region, 2020, 2024 & 2031
2.2 Mesalazine API Segment by Type
2.2.1 Above 97 %
2.2.2 Above 98 %
2.2.3 Above 99 %
2.3 Mesalazine API Sales by Type
2.3.1 Global Mesalazine API Sales Market Share by Type (2020-2025)
2.3.2 Global Mesalazine API Revenue and Market Share by Type (2020-2025)
2.3.3 Global Mesalazine API Sale Price by Type (2020-2025)
2.4 Mesalazine API Segment by Application
2.4.1 Tablets
2.4.2 Capsules
2.4.3 Granule
2.4.4 Suppository
2.4.5 Enema
2.4.6 Others
2.5 Mesalazine API Sales by Application
2.5.1 Global Mesalazine API Sale Market Share by Application (2020-2025)
2.5.2 Global Mesalazine API Revenue and Market Share by Application (2020-2025)
2.5.3 Global Mesalazine API Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Mesalazine API Breakdown Data by Company
3.1.1 Global Mesalazine API Annual Sales by Company (2020-2025)
3.1.2 Global Mesalazine API Sales Market Share by Company (2020-2025)
3.2 Global Mesalazine API Annual Revenue by Company (2020-2025)
3.2.1 Global Mesalazine API Revenue by Company (2020-2025)
3.2.2 Global Mesalazine API Revenue Market Share by Company (2020-2025)
3.3 Global Mesalazine API Sale Price by Company
3.4 Key Manufacturers Mesalazine API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mesalazine API Product Location Distribution
3.4.2 Players Mesalazine API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MESALAZINE API BY GEOGRAPHIC REGION
4.1 World Historic Mesalazine API Market Size by Geographic Region (2020-2025)
4.1.1 Global Mesalazine API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Mesalazine API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Mesalazine API Market Size by Country/Region (2020-2025)
4.2.1 Global Mesalazine API Annual Sales by Country/Region (2020-2025)
4.2.2 Global Mesalazine API Annual Revenue by Country/Region (2020-2025)
4.3 Americas Mesalazine API Sales Growth
4.4 APAC Mesalazine API Sales Growth
4.5 Europe Mesalazine API Sales Growth
4.6 Middle East & Africa Mesalazine API Sales Growth
5 AMERICAS
5.1 Americas Mesalazine API Sales by Country
5.1.1 Americas Mesalazine API Sales by Country (2020-2025)
5.1.2 Americas Mesalazine API Revenue by Country (2020-2025)
5.2 Americas Mesalazine API Sales by Type (2020-2025)
5.3 Americas Mesalazine API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mesalazine API Sales by Region
6.1.1 APAC Mesalazine API Sales by Region (2020-2025)
6.1.2 APAC Mesalazine API Revenue by Region (2020-2025)
6.2 APAC Mesalazine API Sales by Type (2020-2025)
6.3 APAC Mesalazine API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mesalazine API by Country
7.1.1 Europe Mesalazine API Sales by Country (2020-2025)
7.1.2 Europe Mesalazine API Revenue by Country (2020-2025)
7.2 Europe Mesalazine API Sales by Type (2020-2025)
7.3 Europe Mesalazine API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mesalazine API by Country
8.1.1 Middle East & Africa Mesalazine API Sales by Country (2020-2025)
8.1.2 Middle East & Africa Mesalazine API Revenue by Country (2020-2025)
8.2 Middle East & Africa Mesalazine API Sales by Type (2020-2025)
8.3 Middle East & Africa Mesalazine API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mesalazine API
10.3 Manufacturing Process Analysis of Mesalazine API
10.4 Industry Chain Structure of Mesalazine API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mesalazine API Distributors
11.3 Mesalazine API Customer
12 WORLD FORECAST REVIEW FOR MESALAZINE API BY GEOGRAPHIC REGION
12.1 Global Mesalazine API Market Size Forecast by Region
12.1.1 Global Mesalazine API Forecast by Region (2026-2031)
12.1.2 Global Mesalazine API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Mesalazine API Forecast by Type (2026-2031)
12.7 Global Mesalazine API Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 PharmaZell
13.1.1 PharmaZell Company Information
13.1.2 PharmaZell Mesalazine API Product Portfolios and Specifications
13.1.3 PharmaZell Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 PharmaZell Main Business Overview
13.1.5 PharmaZell Latest Developments
13.2 Syntese A/S
13.2.1 Syntese A/S Company Information
13.2.2 Syntese A/S Mesalazine API Product Portfolios and Specifications
13.2.3 Syntese A/S Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Syntese A/S Main Business Overview
13.2.5 Syntese A/S Latest Developments
13.3 Cambrex Corporation
13.3.1 Cambrex Corporation Company Information
13.3.2 Cambrex Corporation Mesalazine API Product Portfolios and Specifications
13.3.3 Cambrex Corporation Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Cambrex Corporation Main Business Overview
13.3.5 Cambrex Corporation Latest Developments
13.4 Divis Laboratories
13.4.1 Divis Laboratories Company Information
13.4.2 Divis Laboratories Mesalazine API Product Portfolios and Specifications
13.4.3 Divis Laboratories Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Divis Laboratories Main Business Overview
13.4.5 Divis Laboratories Latest Developments
13.5 Chemi SpA
13.5.1 Chemi SpA Company Information
13.5.2 Chemi SpA Mesalazine API Product Portfolios and Specifications
13.5.3 Chemi SpA Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Chemi SpA Main Business Overview
13.5.5 Chemi SpA Latest Developments
13.6 Ipca Laboratories
13.6.1 Ipca Laboratories Company Information
13.6.2 Ipca Laboratories Mesalazine API Product Portfolios and Specifications
13.6.3 Ipca Laboratories Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ipca Laboratories Main Business Overview
13.6.5 Ipca Laboratories Latest Developments
13.7 Hangzhou Brother
13.7.1 Hangzhou Brother Company Information
13.7.2 Hangzhou Brother Mesalazine API Product Portfolios and Specifications
13.7.3 Hangzhou Brother Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hangzhou Brother Main Business Overview
13.7.5 Hangzhou Brother Latest Developments
13.8 Lianyungang Fengheng Biopharm
13.8.1 Lianyungang Fengheng Biopharm Company Information
13.8.2 Lianyungang Fengheng Biopharm Mesalazine API Product Portfolios and Specifications
13.8.3 Lianyungang Fengheng Biopharm Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Lianyungang Fengheng Biopharm Main Business Overview
13.8.5 Lianyungang Fengheng Biopharm Latest Developments
13.9 Lasa Loboratory
13.9.1 Lasa Loboratory Company Information
13.9.2 Lasa Loboratory Mesalazine API Product Portfolios and Specifications
13.9.3 Lasa Loboratory Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Lasa Loboratory Main Business Overview
13.9.5 Lasa Loboratory Latest Developments
13.10 Corden Pharma Bergamo
13.10.1 Corden Pharma Bergamo Company Information
13.10.2 Corden Pharma Bergamo Mesalazine API Product Portfolios and Specifications
13.10.3 Corden Pharma Bergamo Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Corden Pharma Bergamo Main Business Overview
13.10.5 Corden Pharma Bergamo Latest Developments
13.11 Erregierre SpA
13.11.1 Erregierre SpA Company Information
13.11.2 Erregierre SpA Mesalazine API Product Portfolios and Specifications
13.11.3 Erregierre SpA Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Erregierre SpA Main Business Overview
13.11.5 Erregierre SpA Latest Developments
13.12 CTX Lifescience
13.12.1 CTX Lifescience Company Information
13.12.2 CTX Lifescience Mesalazine API Product Portfolios and Specifications
13.12.3 CTX Lifescience Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 CTX Lifescience Main Business Overview
13.12.5 CTX Lifescience Latest Developments
13.13 Ishita Active Pharma Ingredients
13.13.1 Ishita Active Pharma Ingredients Company Information
13.13.2 Ishita Active Pharma Ingredients Mesalazine API Product Portfolios and Specifications
13.13.3 Ishita Active Pharma Ingredients Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Ishita Active Pharma Ingredients Main Business Overview
13.13.5 Ishita Active Pharma Ingredients Latest Developments
13.14 YC Biotech (Jiangsu)
13.14.1 YC Biotech (Jiangsu) Company Information
13.14.2 YC Biotech (Jiangsu) Mesalazine API Product Portfolios and Specifications
13.14.3 YC Biotech (Jiangsu) Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 YC Biotech (Jiangsu) Main Business Overview
13.14.5 YC Biotech (Jiangsu) Latest Developments
13.15 Xinxiang Tianfeng Fine Chemical
13.15.1 Xinxiang Tianfeng Fine Chemical Company Information
13.15.2 Xinxiang Tianfeng Fine Chemical Mesalazine API Product Portfolios and Specifications
13.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine API Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Xinxiang Tianfeng Fine Chemical Main Business Overview
13.15.5 Xinxiang Tianfeng Fine Chemical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Mesalazine API Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Mesalazine API Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Above 97 %
Table 4. Major Players of Above 98 %
Table 5. Major Players of Above 99 %
Table 6. Global Mesalazine API Sales by Type (2020-2025) & (Tons)
Table 7. Global Mesalazine API Sales Market Share by Type (2020-2025)
Table 8. Global Mesalazine API Revenue by Type (2020-2025) & ($ million)
Table 9. Global Mesalazine API Revenue Market Share by Type (2020-2025)
Table 10. Global Mesalazine API Sale Price by Type (2020-2025) & (US$/kg)
Table 11. Global Mesalazine API Sale by Application (2020-2025) & (Tons)
Table 12. Global Mesalazine API Sale Market Share by Application (2020-2025)
Table 13. Global Mesalazine API Revenue by Application (2020-2025) & ($ million)
Table 14. Global Mesalazine API Revenue Market Share by Application (2020-2025)
Table 15. Global Mesalazine API Sale Price by Application (2020-2025) & (US$/kg)
Table 16. Global Mesalazine API Sales by Company (2020-2025) & (Tons)
Table 17. Global Mesalazine API Sales Market Share by Company (2020-2025)
Table 18. Global Mesalazine API Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Mesalazine API Revenue Market Share by Company (2020-2025)
Table 20. Global Mesalazine API Sale Price by Company (2020-2025) & (US$/kg)
Table 21. Key Manufacturers Mesalazine API Producing Area Distribution and Sales Area
Table 22. Players Mesalazine API Products Offered
Table 23. Mesalazine API Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Mesalazine API Sales by Geographic Region (2020-2025) & (Tons)
Table 27. Global Mesalazine API Sales Market Share Geographic Region (2020-2025)
Table 28. Global Mesalazine API Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Mesalazine API Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Mesalazine API Sales by Country/Region (2020-2025) & (Tons)
Table 31. Global Mesalazine API Sales Market Share by Country/Region (2020-2025)
Table 32. Global Mesalazine API Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Mesalazine API Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Mesalazine API Sales by Country (2020-2025) & (Tons)
Table 35. Americas Mesalazine API Sales Market Share by Country (2020-2025)
Table 36. Americas Mesalazine API Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Mesalazine API Sales by Type (2020-2025) & (Tons)
Table 38. Americas Mesalazine API Sales by Application (2020-2025) & (Tons)
Table 39. APAC Mesalazine API Sales by Region (2020-2025) & (Tons)
Table 40. APAC Mesalazine API Sales Market Share by Region (2020-2025)
Table 41. APAC Mesalazine API Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Mesalazine API Sales by Type (2020-2025) & (Tons)
Table 43. APAC Mesalazine API Sales by Application (2020-2025) & (Tons)
Table 44. Europe Mesalazine API Sales by Country (2020-2025) & (Tons)
Table 45. Europe Mesalazine API Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Mesalazine API Sales by Type (2020-2025) & (Tons)
Table 47. Europe Mesalazine API Sales by Application (2020-2025) & (Tons)
Table 48. Middle East & Africa Mesalazine API Sales by Country (2020-2025) & (Tons)
Table 49. Middle East & Africa Mesalazine API Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Mesalazine API Sales by Type (2020-2025) & (Tons)
Table 51. Middle East & Africa Mesalazine API Sales by Application (2020-2025) & (Tons)
Table 52. Key Market Drivers & Growth Opportunities of Mesalazine API
Table 53. Key Market Challenges & Risks of Mesalazine API
Table 54. Key Industry Trends of Mesalazine API
Table 55. Mesalazine API Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Mesalazine API Distributors List
Table 58. Mesalazine API Customer List
Table 59. Global Mesalazine API Sales Forecast by Region (2026-2031) & (Tons)
Table 60. Global Mesalazine API Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Mesalazine API Sales Forecast by Country (2026-2031) & (Tons)
Table 62. Americas Mesalazine API Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Mesalazine API Sales Forecast by Region (2026-2031) & (Tons)
Table 64. APAC Mesalazine API Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Mesalazine API Sales Forecast by Country (2026-2031) & (Tons)
Table 66. Europe Mesalazine API Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Mesalazine API Sales Forecast by Country (2026-2031) & (Tons)
Table 68. Middle East & Africa Mesalazine API Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Mesalazine API Sales Forecast by Type (2026-2031) & (Tons)
Table 70. Global Mesalazine API Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Mesalazine API Sales Forecast by Application (2026-2031) & (Tons)
Table 72. Global Mesalazine API Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. PharmaZell Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 74. PharmaZell Mesalazine API Product Portfolios and Specifications
Table 75. PharmaZell Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 76. PharmaZell Main Business
Table 77. PharmaZell Latest Developments
Table 78. Syntese A/S Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 79. Syntese A/S Mesalazine API Product Portfolios and Specifications
Table 80. Syntese A/S Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 81. Syntese A/S Main Business
Table 82. Syntese A/S Latest Developments
Table 83. Cambrex Corporation Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 84. Cambrex Corporation Mesalazine API Product Portfolios and Specifications
Table 85. Cambrex Corporation Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 86. Cambrex Corporation Main Business
Table 87. Cambrex Corporation Latest Developments
Table 88. Divis Laboratories Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 89. Divis Laboratories Mesalazine API Product Portfolios and Specifications
Table 90. Divis Laboratories Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 91. Divis Laboratories Main Business
Table 92. Divis Laboratories Latest Developments
Table 93. Chemi SpA Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 94. Chemi SpA Mesalazine API Product Portfolios and Specifications
Table 95. Chemi SpA Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 96. Chemi SpA Main Business
Table 97. Chemi SpA Latest Developments
Table 98. Ipca Laboratories Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 99. Ipca Laboratories Mesalazine API Product Portfolios and Specifications
Table 100. Ipca Laboratories Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 101. Ipca Laboratories Main Business
Table 102. Ipca Laboratories Latest Developments
Table 103. Hangzhou Brother Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 104. Hangzhou Brother Mesalazine API Product Portfolios and Specifications
Table 105. Hangzhou Brother Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 106. Hangzhou Brother Main Business
Table 107. Hangzhou Brother Latest Developments
Table 108. Lianyungang Fengheng Biopharm Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 109. Lianyungang Fengheng Biopharm Mesalazine API Product Portfolios and Specifications
Table 110. Lianyungang Fengheng Biopharm Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 111. Lianyungang Fengheng Biopharm Main Business
Table 112. Lianyungang Fengheng Biopharm Latest Developments
Table 113. Lasa Loboratory Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 114. Lasa Loboratory Mesalazine API Product Portfolios and Specifications
Table 115. Lasa Loboratory Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 116. Lasa Loboratory Main Business
Table 117. Lasa Loboratory Latest Developments
Table 118. Corden Pharma Bergamo Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 119. Corden Pharma Bergamo Mesalazine API Product Portfolios and Specifications
Table 120. Corden Pharma Bergamo Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 121. Corden Pharma Bergamo Main Business
Table 122. Corden Pharma Bergamo Latest Developments
Table 123. Erregierre SpA Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 124. Erregierre SpA Mesalazine API Product Portfolios and Specifications
Table 125. Erregierre SpA Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 126. Erregierre SpA Main Business
Table 127. Erregierre SpA Latest Developments
Table 128. CTX Lifescience Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 129. CTX Lifescience Mesalazine API Product Portfolios and Specifications
Table 130. CTX Lifescience Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 131. CTX Lifescience Main Business
Table 132. CTX Lifescience Latest Developments
Table 133. Ishita Active Pharma Ingredients Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 134. Ishita Active Pharma Ingredients Mesalazine API Product Portfolios and Specifications
Table 135. Ishita Active Pharma Ingredients Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 136. Ishita Active Pharma Ingredients Main Business
Table 137. Ishita Active Pharma Ingredients Latest Developments
Table 138. YC Biotech (Jiangsu) Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 139. YC Biotech (Jiangsu) Mesalazine API Product Portfolios and Specifications
Table 140. YC Biotech (Jiangsu) Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 141. YC Biotech (Jiangsu) Main Business
Table 142. YC Biotech (Jiangsu) Latest Developments
Table 143. Xinxiang Tianfeng Fine Chemical Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 144. Xinxiang Tianfeng Fine Chemical Mesalazine API Product Portfolios and Specifications
Table 145. Xinxiang Tianfeng Fine Chemical Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 146. Xinxiang Tianfeng Fine Chemical Main Business
Table 147. Xinxiang Tianfeng Fine Chemical Latest Developments
Table 1. Mesalazine API Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Mesalazine API Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Above 97 %
Table 4. Major Players of Above 98 %
Table 5. Major Players of Above 99 %
Table 6. Global Mesalazine API Sales by Type (2020-2025) & (Tons)
Table 7. Global Mesalazine API Sales Market Share by Type (2020-2025)
Table 8. Global Mesalazine API Revenue by Type (2020-2025) & ($ million)
Table 9. Global Mesalazine API Revenue Market Share by Type (2020-2025)
Table 10. Global Mesalazine API Sale Price by Type (2020-2025) & (US$/kg)
Table 11. Global Mesalazine API Sale by Application (2020-2025) & (Tons)
Table 12. Global Mesalazine API Sale Market Share by Application (2020-2025)
Table 13. Global Mesalazine API Revenue by Application (2020-2025) & ($ million)
Table 14. Global Mesalazine API Revenue Market Share by Application (2020-2025)
Table 15. Global Mesalazine API Sale Price by Application (2020-2025) & (US$/kg)
Table 16. Global Mesalazine API Sales by Company (2020-2025) & (Tons)
Table 17. Global Mesalazine API Sales Market Share by Company (2020-2025)
Table 18. Global Mesalazine API Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Mesalazine API Revenue Market Share by Company (2020-2025)
Table 20. Global Mesalazine API Sale Price by Company (2020-2025) & (US$/kg)
Table 21. Key Manufacturers Mesalazine API Producing Area Distribution and Sales Area
Table 22. Players Mesalazine API Products Offered
Table 23. Mesalazine API Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Mesalazine API Sales by Geographic Region (2020-2025) & (Tons)
Table 27. Global Mesalazine API Sales Market Share Geographic Region (2020-2025)
Table 28. Global Mesalazine API Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Mesalazine API Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Mesalazine API Sales by Country/Region (2020-2025) & (Tons)
Table 31. Global Mesalazine API Sales Market Share by Country/Region (2020-2025)
Table 32. Global Mesalazine API Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Mesalazine API Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Mesalazine API Sales by Country (2020-2025) & (Tons)
Table 35. Americas Mesalazine API Sales Market Share by Country (2020-2025)
Table 36. Americas Mesalazine API Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Mesalazine API Sales by Type (2020-2025) & (Tons)
Table 38. Americas Mesalazine API Sales by Application (2020-2025) & (Tons)
Table 39. APAC Mesalazine API Sales by Region (2020-2025) & (Tons)
Table 40. APAC Mesalazine API Sales Market Share by Region (2020-2025)
Table 41. APAC Mesalazine API Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Mesalazine API Sales by Type (2020-2025) & (Tons)
Table 43. APAC Mesalazine API Sales by Application (2020-2025) & (Tons)
Table 44. Europe Mesalazine API Sales by Country (2020-2025) & (Tons)
Table 45. Europe Mesalazine API Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Mesalazine API Sales by Type (2020-2025) & (Tons)
Table 47. Europe Mesalazine API Sales by Application (2020-2025) & (Tons)
Table 48. Middle East & Africa Mesalazine API Sales by Country (2020-2025) & (Tons)
Table 49. Middle East & Africa Mesalazine API Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Mesalazine API Sales by Type (2020-2025) & (Tons)
Table 51. Middle East & Africa Mesalazine API Sales by Application (2020-2025) & (Tons)
Table 52. Key Market Drivers & Growth Opportunities of Mesalazine API
Table 53. Key Market Challenges & Risks of Mesalazine API
Table 54. Key Industry Trends of Mesalazine API
Table 55. Mesalazine API Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Mesalazine API Distributors List
Table 58. Mesalazine API Customer List
Table 59. Global Mesalazine API Sales Forecast by Region (2026-2031) & (Tons)
Table 60. Global Mesalazine API Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Mesalazine API Sales Forecast by Country (2026-2031) & (Tons)
Table 62. Americas Mesalazine API Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Mesalazine API Sales Forecast by Region (2026-2031) & (Tons)
Table 64. APAC Mesalazine API Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Mesalazine API Sales Forecast by Country (2026-2031) & (Tons)
Table 66. Europe Mesalazine API Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Mesalazine API Sales Forecast by Country (2026-2031) & (Tons)
Table 68. Middle East & Africa Mesalazine API Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Mesalazine API Sales Forecast by Type (2026-2031) & (Tons)
Table 70. Global Mesalazine API Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Mesalazine API Sales Forecast by Application (2026-2031) & (Tons)
Table 72. Global Mesalazine API Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. PharmaZell Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 74. PharmaZell Mesalazine API Product Portfolios and Specifications
Table 75. PharmaZell Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 76. PharmaZell Main Business
Table 77. PharmaZell Latest Developments
Table 78. Syntese A/S Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 79. Syntese A/S Mesalazine API Product Portfolios and Specifications
Table 80. Syntese A/S Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 81. Syntese A/S Main Business
Table 82. Syntese A/S Latest Developments
Table 83. Cambrex Corporation Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 84. Cambrex Corporation Mesalazine API Product Portfolios and Specifications
Table 85. Cambrex Corporation Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 86. Cambrex Corporation Main Business
Table 87. Cambrex Corporation Latest Developments
Table 88. Divis Laboratories Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 89. Divis Laboratories Mesalazine API Product Portfolios and Specifications
Table 90. Divis Laboratories Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 91. Divis Laboratories Main Business
Table 92. Divis Laboratories Latest Developments
Table 93. Chemi SpA Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 94. Chemi SpA Mesalazine API Product Portfolios and Specifications
Table 95. Chemi SpA Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 96. Chemi SpA Main Business
Table 97. Chemi SpA Latest Developments
Table 98. Ipca Laboratories Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 99. Ipca Laboratories Mesalazine API Product Portfolios and Specifications
Table 100. Ipca Laboratories Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 101. Ipca Laboratories Main Business
Table 102. Ipca Laboratories Latest Developments
Table 103. Hangzhou Brother Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 104. Hangzhou Brother Mesalazine API Product Portfolios and Specifications
Table 105. Hangzhou Brother Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 106. Hangzhou Brother Main Business
Table 107. Hangzhou Brother Latest Developments
Table 108. Lianyungang Fengheng Biopharm Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 109. Lianyungang Fengheng Biopharm Mesalazine API Product Portfolios and Specifications
Table 110. Lianyungang Fengheng Biopharm Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 111. Lianyungang Fengheng Biopharm Main Business
Table 112. Lianyungang Fengheng Biopharm Latest Developments
Table 113. Lasa Loboratory Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 114. Lasa Loboratory Mesalazine API Product Portfolios and Specifications
Table 115. Lasa Loboratory Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 116. Lasa Loboratory Main Business
Table 117. Lasa Loboratory Latest Developments
Table 118. Corden Pharma Bergamo Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 119. Corden Pharma Bergamo Mesalazine API Product Portfolios and Specifications
Table 120. Corden Pharma Bergamo Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 121. Corden Pharma Bergamo Main Business
Table 122. Corden Pharma Bergamo Latest Developments
Table 123. Erregierre SpA Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 124. Erregierre SpA Mesalazine API Product Portfolios and Specifications
Table 125. Erregierre SpA Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 126. Erregierre SpA Main Business
Table 127. Erregierre SpA Latest Developments
Table 128. CTX Lifescience Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 129. CTX Lifescience Mesalazine API Product Portfolios and Specifications
Table 130. CTX Lifescience Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 131. CTX Lifescience Main Business
Table 132. CTX Lifescience Latest Developments
Table 133. Ishita Active Pharma Ingredients Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 134. Ishita Active Pharma Ingredients Mesalazine API Product Portfolios and Specifications
Table 135. Ishita Active Pharma Ingredients Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 136. Ishita Active Pharma Ingredients Main Business
Table 137. Ishita Active Pharma Ingredients Latest Developments
Table 138. YC Biotech (Jiangsu) Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 139. YC Biotech (Jiangsu) Mesalazine API Product Portfolios and Specifications
Table 140. YC Biotech (Jiangsu) Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 141. YC Biotech (Jiangsu) Main Business
Table 142. YC Biotech (Jiangsu) Latest Developments
Table 143. Xinxiang Tianfeng Fine Chemical Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 144. Xinxiang Tianfeng Fine Chemical Mesalazine API Product Portfolios and Specifications
Table 145. Xinxiang Tianfeng Fine Chemical Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 146. Xinxiang Tianfeng Fine Chemical Main Business
Table 147. Xinxiang Tianfeng Fine Chemical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Mesalazine API
Figure 2. Mesalazine API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mesalazine API Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Mesalazine API Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Mesalazine API Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Mesalazine API Sales Market Share by Country/Region (2024)
Figure 10. Mesalazine API Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Above 97 %
Figure 12. Product Picture of Above 98 %
Figure 13. Product Picture of Above 99 %
Figure 14. Global Mesalazine API Sales Market Share by Type in 2025
Figure 15. Global Mesalazine API Revenue Market Share by Type (2020-2025)
Figure 16. Mesalazine API Consumed inTablets
Figure 17. Global Mesalazine API Market:Tablets (2020-2025) & (Tons)
Figure 18. Mesalazine API Consumed in Capsules
Figure 19. Global Mesalazine API Market: Capsules (2020-2025) & (Tons)
Figure 20. Mesalazine API Consumed in Granule
Figure 21. Global Mesalazine API Market: Granule (2020-2025) & (Tons)
Figure 22. Mesalazine API Consumed in Suppository
Figure 23. Global Mesalazine API Market: Suppository (2020-2025) & (Tons)
Figure 24. Mesalazine API Consumed in Enema
Figure 25. Global Mesalazine API Market: Enema (2020-2025) & (Tons)
Figure 26. Mesalazine API Consumed in Others
Figure 27. Global Mesalazine API Market: Others (2020-2025) & (Tons)
Figure 28. Global Mesalazine API Sale Market Share by Application (2024)
Figure 29. Global Mesalazine API Revenue Market Share by Application in 2025
Figure 30. Mesalazine API Sales by Company in 2025 (Tons)
Figure 31. Global Mesalazine API Sales Market Share by Company in 2025
Figure 32. Mesalazine API Revenue by Company in 2025 ($ millions)
Figure 33. Global Mesalazine API Revenue Market Share by Company in 2025
Figure 34. Global Mesalazine API Sales Market Share by Geographic Region (2020-2025)
Figure 35. Global Mesalazine API Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Mesalazine API Sales 2020-2025 (Tons)
Figure 37. Americas Mesalazine API Revenue 2020-2025 ($ millions)
Figure 38. APAC Mesalazine API Sales 2020-2025 (Tons)
Figure 39. APAC Mesalazine API Revenue 2020-2025 ($ millions)
Figure 40. Europe Mesalazine API Sales 2020-2025 (Tons)
Figure 41. Europe Mesalazine API Revenue 2020-2025 ($ millions)
Figure 42. Middle East & Africa Mesalazine API Sales 2020-2025 (Tons)
Figure 43. Middle East & Africa Mesalazine API Revenue 2020-2025 ($ millions)
Figure 44. Americas Mesalazine API Sales Market Share by Country in 2025
Figure 45. Americas Mesalazine API Revenue Market Share by Country (2020-2025)
Figure 46. Americas Mesalazine API Sales Market Share by Type (2020-2025)
Figure 47. Americas Mesalazine API Sales Market Share by Application (2020-2025)
Figure 48. United States Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 49. Canada Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 50. Mexico Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 51. Brazil Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 52. APAC Mesalazine API Sales Market Share by Region in 2025
Figure 53. APAC Mesalazine API Revenue Market Share by Region (2020-2025)
Figure 54. APAC Mesalazine API Sales Market Share by Type (2020-2025)
Figure 55. APAC Mesalazine API Sales Market Share by Application (2020-2025)
Figure 56. China Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 57. Japan Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 58. South Korea Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 59. Southeast Asia Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 60. India Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 61. Australia Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 62. China Taiwan Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 63. Europe Mesalazine API Sales Market Share by Country in 2025
Figure 64. Europe Mesalazine API Revenue Market Share by Country (2020-2025)
Figure 65. Europe Mesalazine API Sales Market Share by Type (2020-2025)
Figure 66. Europe Mesalazine API Sales Market Share by Application (2020-2025)
Figure 67. Germany Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 68. France Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 69. UK Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 70. Italy Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 71. Russia Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 72. Middle East & Africa Mesalazine API Sales Market Share by Country (2020-2025)
Figure 73. Middle East & Africa Mesalazine API Sales Market Share by Type (2020-2025)
Figure 74. Middle East & Africa Mesalazine API Sales Market Share by Application (2020-2025)
Figure 75. Egypt Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 76. South Africa Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 77. Israel Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 78. Turkey Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 79. GCC Countries Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Mesalazine API in 2025
Figure 81. Manufacturing Process Analysis of Mesalazine API
Figure 82. Industry Chain Structure of Mesalazine API
Figure 83. Channels of Distribution
Figure 84. Global Mesalazine API Sales Market Forecast by Region (2026-2031)
Figure 85. Global Mesalazine API Revenue Market Share Forecast by Region (2026-2031)
Figure 86. Global Mesalazine API Sales Market Share Forecast by Type (2026-2031)
Figure 87. Global Mesalazine API Revenue Market Share Forecast by Type (2026-2031)
Figure 88. Global Mesalazine API Sales Market Share Forecast by Application (2026-2031)
Figure 89. Global Mesalazine API Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Mesalazine API
Figure 2. Mesalazine API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mesalazine API Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Mesalazine API Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Mesalazine API Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Mesalazine API Sales Market Share by Country/Region (2024)
Figure 10. Mesalazine API Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Above 97 %
Figure 12. Product Picture of Above 98 %
Figure 13. Product Picture of Above 99 %
Figure 14. Global Mesalazine API Sales Market Share by Type in 2025
Figure 15. Global Mesalazine API Revenue Market Share by Type (2020-2025)
Figure 16. Mesalazine API Consumed inTablets
Figure 17. Global Mesalazine API Market:Tablets (2020-2025) & (Tons)
Figure 18. Mesalazine API Consumed in Capsules
Figure 19. Global Mesalazine API Market: Capsules (2020-2025) & (Tons)
Figure 20. Mesalazine API Consumed in Granule
Figure 21. Global Mesalazine API Market: Granule (2020-2025) & (Tons)
Figure 22. Mesalazine API Consumed in Suppository
Figure 23. Global Mesalazine API Market: Suppository (2020-2025) & (Tons)
Figure 24. Mesalazine API Consumed in Enema
Figure 25. Global Mesalazine API Market: Enema (2020-2025) & (Tons)
Figure 26. Mesalazine API Consumed in Others
Figure 27. Global Mesalazine API Market: Others (2020-2025) & (Tons)
Figure 28. Global Mesalazine API Sale Market Share by Application (2024)
Figure 29. Global Mesalazine API Revenue Market Share by Application in 2025
Figure 30. Mesalazine API Sales by Company in 2025 (Tons)
Figure 31. Global Mesalazine API Sales Market Share by Company in 2025
Figure 32. Mesalazine API Revenue by Company in 2025 ($ millions)
Figure 33. Global Mesalazine API Revenue Market Share by Company in 2025
Figure 34. Global Mesalazine API Sales Market Share by Geographic Region (2020-2025)
Figure 35. Global Mesalazine API Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Mesalazine API Sales 2020-2025 (Tons)
Figure 37. Americas Mesalazine API Revenue 2020-2025 ($ millions)
Figure 38. APAC Mesalazine API Sales 2020-2025 (Tons)
Figure 39. APAC Mesalazine API Revenue 2020-2025 ($ millions)
Figure 40. Europe Mesalazine API Sales 2020-2025 (Tons)
Figure 41. Europe Mesalazine API Revenue 2020-2025 ($ millions)
Figure 42. Middle East & Africa Mesalazine API Sales 2020-2025 (Tons)
Figure 43. Middle East & Africa Mesalazine API Revenue 2020-2025 ($ millions)
Figure 44. Americas Mesalazine API Sales Market Share by Country in 2025
Figure 45. Americas Mesalazine API Revenue Market Share by Country (2020-2025)
Figure 46. Americas Mesalazine API Sales Market Share by Type (2020-2025)
Figure 47. Americas Mesalazine API Sales Market Share by Application (2020-2025)
Figure 48. United States Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 49. Canada Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 50. Mexico Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 51. Brazil Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 52. APAC Mesalazine API Sales Market Share by Region in 2025
Figure 53. APAC Mesalazine API Revenue Market Share by Region (2020-2025)
Figure 54. APAC Mesalazine API Sales Market Share by Type (2020-2025)
Figure 55. APAC Mesalazine API Sales Market Share by Application (2020-2025)
Figure 56. China Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 57. Japan Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 58. South Korea Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 59. Southeast Asia Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 60. India Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 61. Australia Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 62. China Taiwan Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 63. Europe Mesalazine API Sales Market Share by Country in 2025
Figure 64. Europe Mesalazine API Revenue Market Share by Country (2020-2025)
Figure 65. Europe Mesalazine API Sales Market Share by Type (2020-2025)
Figure 66. Europe Mesalazine API Sales Market Share by Application (2020-2025)
Figure 67. Germany Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 68. France Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 69. UK Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 70. Italy Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 71. Russia Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 72. Middle East & Africa Mesalazine API Sales Market Share by Country (2020-2025)
Figure 73. Middle East & Africa Mesalazine API Sales Market Share by Type (2020-2025)
Figure 74. Middle East & Africa Mesalazine API Sales Market Share by Application (2020-2025)
Figure 75. Egypt Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 76. South Africa Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 77. Israel Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 78. Turkey Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 79. GCC Countries Mesalazine API Revenue Growth 2020-2025 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Mesalazine API in 2025
Figure 81. Manufacturing Process Analysis of Mesalazine API
Figure 82. Industry Chain Structure of Mesalazine API
Figure 83. Channels of Distribution
Figure 84. Global Mesalazine API Sales Market Forecast by Region (2026-2031)
Figure 85. Global Mesalazine API Revenue Market Share Forecast by Region (2026-2031)
Figure 86. Global Mesalazine API Sales Market Share Forecast by Type (2026-2031)
Figure 87. Global Mesalazine API Revenue Market Share Forecast by Type (2026-2031)
Figure 88. Global Mesalazine API Sales Market Share Forecast by Application (2026-2031)
Figure 89. Global Mesalazine API Revenue Market Share Forecast by Application (2026-2031)
